Tolerability of high doses of lercanidipine versus high doses of other dihydropyridines in daily clinical practice: The TOLERANCE study

Cardiovascular Therapeutics

Volumn 26, Issue 1, 2008, Pages 2-9

  Barrios, Vivencio ^a   Escobar, Carlos ^a   De La Figuera, Mariano ^b   Llisterri, Jose Luis ^c   Honorato, Jesus ^d   Segura, Julián ^e   Calderón, Alberto ^f  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b CAP La Mina   (Spain)

^c C S Ingeniero Joaquín Benlloch   (Spain)

^d UNIVERSITY CLINIC OF NAVARRA   (Spain)

^e HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^f CS Rosa de Luxemburgo ^*  (Spain)

Author keywords

Adverse effects; Amlodipine; Antihypertensive drugs; Dihydropyridines; Hypertension; Lercanipine; Nifedipine GITS; Tolerability; Vasodilation

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AMLODIPINE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIHYDROPYRIDINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; LERCANIDIPINE; NIFEDIPINE;

ADULT; AGED; ARTICLE; BLURRED VISION; CLINICAL PRACTICE; CONSTIPATION; CONTROLLED STUDY; DIARRHEA; DIZZINESS; DRUG MEGADOSE; DRUG TOLERABILITY; DYSPNEA; FATIGUE; FEMALE; FLUSHING; FOLLOW UP; GUM SWELLING; HEADACHE; HEART PALPITATION; HEARTBURN; HUMAN; HYPERTENSION; INCIDENCE; LEG EDEMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RASH; SEXUAL DYSFUNCTION; SIDE EFFECT; SWELLING; THORACIC SWELLING; THORAX PAIN; VASODILATATION;

AGED; AMLODIPINE; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; CROSS-SECTIONAL STUDIES; DIHYDROPYRIDINES; FEMALE; HEART RATE; HUMANS; HYPERTENSION; LOGISTIC MODELS; MALE; MIDDLE AGED; NIFEDIPINE; PRIMARY HEALTH CARE; SPAIN; VASODILATION;

EID: 47049109415     PISSN: 17555914     EISSN: 17555922     Source Type: Journal    
DOI: 10.1111/j.1527-3466.2007.00035.x     Document Type: Article

References (33)

1. Agrawal R, Marx A, Haller H (2006) Efficacy and safety of lercanidipine versus hydrochlorothiazide as add-on to enalapril in diabetic populations with uncontrolled hypertension. J Hypertens 24 : 185 192.
2. Ambrosioni E, Circo A (1997) Activity of lercanidipine administered in single and repeated doses once daily as monitored over 24 hours in patients with mild to moderate essential hypertension. J Cardiovasc Pharmacol 29 (Suppl 2 S16 20.
3. American Diabetes Association (2005) Clinical Practice Recommendations 2005. Diabetes Care 28 (Suppl 1 S1 79.
4. Angelico P, Guarnieri N, Leonardi A, Testa R (1999) Vascular-selective effect of lercanidipine and other 1,4 dihydropyridines in isolated rabbit tissues. J Pharm Pharmacol 51 : 709 714.
5. Bang LM, Chapman TM, Goa KL (2003) Lercanidipine: A review of its efficacy in the management of hypertension. Drugs 63 : 2449 2472.
6. Barbagallo M, Barbagallo Sangiorgi G (2000) Efficacy and tolerability of lercanidipine in monotherapy in elderly patients with isolated systolic hypertension. Aging 12 : 375 379.
7. Barrios V, Navarro A, Esteras A, Luque M, Romero J, Tamargo J, et al 2002) Investigators of ELYPSE Study (Eficacia de Lercanidipino y su Perfil de Seguridad). Antihypertensive efficacy and tolerability of lercanidipine in daily clinical practice. The ELYPSE Study. Blood Press 11 : 95 100.
8. Barrios V, Escobar C, Navarro A, Barrios L, Navarro-Cid J, Calderon A LAURA Investigators (2006a) Lercanidipine is an effective and well tolerated antihypertensive drug regardless the cardiovascular risk profile: The LAURA study. Int J Clin Pract 60 : 1364 1370.
9. Barrios V, Escobar C, Calderon A, Navarro A, Ruilope LM (2006b) The effectiveness and tolerability of lercanidipine is independent of body mass index or body fat percent. The LERZAMIG study. Br J Cardiol 13 : 433 440.
10. Beckey C, Lundy A, Lutfi N (2007) Lercanidipine in the treatment of hypertension. Ann Pharmacother 41 : 465 473.
11. Borghi C, Prandin MG, Dormi A, Ambrosioni E Study Group of the Regional Unit of the Italian Society of Hypertension (2003) Improved tolerability of the dihydropyridine calcium-channel antagonist lercanidipine: The lercanidipine challenge trial. Blood Press (Suppl 1 14 21.
12. Cherubini A, Fabris F, Ferrari E, Cucinotta D, Antonelli Incalzi R, Senin U (2003) Comparative effects of lercanidipine, lacidipine, and nifedipine gastrointestinal therapeutic system on blood pressure and heart rate in elderly hypertensive patients: The ELderly and LErcanidipine (ELLE) study. Arch Gerontol Geriatr 37 : 203 212.
13. Cushman WC, Ford CE, Cutler JA, Margolis KL, Davis BR, Grimm RH, Black HR, Hamilton BP, Holland J, Nwachuku C, et al. ALLHAT Collaborative Research Group (2002) Success and predictors of blood pressure control in diverse North American settings. The Antihypertensive and Lipid-Lowering treatment to prevent Heart Attack Trial (ALLHAT). J Clin Hypertens 4 : 393 404.
14. European Society of Hypertension-European Society of Cardiology Guidelines Committee (2003) 2003 European Society of Hypertension - European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 21 : 1011 1153.
15. Fogari R, Mugellini A, Zoppi A, Corradi L, Rianldi A, Derosa G, Preti P (2003) Differential effects of lercanidipine and nifedipine GITS on plasma norepinephrine in chronic treatment of hypertension. Am J Hypertens 16 : 596 599.
16. Gil V, Marinez JL, Munoz C, Alberola T, Belda J, Merino J (1993) A four year study of therapeutical observation of patients with hipertensión. Rev Clin Esp 193 : 351 356.
17. Grassi G, Serravalle G, Turri C, Bertinieri G, Stella ML, Mancia G (1998) Different behaviour of the sympathetic responses to acute and chronic blood pressure reductions induced by antihypertensive drugs. J Hypertens 16 : 1357 1369.
18. James IG, Jones A, Davies P (2002) A randomised, double-blind, double-dummy comparison of the efficacy and tolerability of lercanidipine tablets and losartan tablets in patients with mild to moderate essential hypertension. J Hum Hypertens 16 : 605 610.
19. Leonetti G (1999) The safety profile of antihypertensive drugs as the key factor for the achievement of blood pressure control: Current experience with lercanidipne. High Blood Press 8 : 92 101.
20. Leonetti G, Magnani B, Pessina AC, Rappelli A, Trimarco B, Zanchetti A, on behalf of the COHORT Study Group (2002) Tolerability of long-term treatment with lercanidipine versus amlodipine and lacidipine in elderly hypertensives. Am J Hypertens 15 : 932 940.
21. Lund-Johansen P, Stranden E, Helberg S, Wessel-Aas T, Risberg K, Ronnevik PK, et al 2003) Quantification of leg oedema in postmenopausal hypertensive patients treated with lercanidipine or amlodipine. J Hypertens 21 : 1003 1010.
22. Meredith PA (1999) Lercanidipine: A novel lipohilic dihydropyridine calcium antagonist with long duration of action and high vascular selectivity. Expert Opin Investig Drugs 8 : 1043 1062.
23. Millar-Craig M, Shaffu B, Greenough A, Mitchell L, McDonald C (2003) Lercanidipine vs. lacidipine in isolated systolic hypertension. J Hum Hypertens 17 : 799 806.
24. Osterberg L, Blaschke T (2005) Adherence to medication. N Engl J Med 353 : 487 497.
25. Pedrinelli R, Dell'Omo G, Nuti M, Menegato A, Balbarini A, Mariani M (2003) Heterogeneous effect of calcium antagonists on leg oedema: A comparison of amlodipine versus lercanidipine in hypertensive patients. J Hypertens 21 : 1969 1973.
26. Policicchio D, Magliocca R, Malliani A (1997) Efficacy and tolerability of lercanidipine in patients with mild to moderate essential hypertension: A comparative study with slow-release nifedipine. J Cardiovasc Pharmacol 29 (Suppl 2 S31 35.
27. Rengo F, Romis L (1997) Activity of lercanidipine in double-blind comparison with nitrendipine in combination treatment of patients with resistant essential hypertension. J Cardiovasc Pharmacol 29 (Suppl 2 S54 58.
28. Romito R, Pansini MI, Perticone F, Antonelli G, Pitzalis M, Rizzon P (2003) Comparative effect of lercanidipine, felodipine, and nifedipine GITS on blood pressure and heart rate in patients with mild to moderate arterial hypertension: The Lercanidipine in Adults (LEAD) Study. J Clin Hypertens 5 : 249 253.
29. Roth MT, Ivey JL (2005) Self-reported medication use in community-residing older adults: A pilot study. Am J Geriatr Pharmacother 3 : 196 204.
30. Sackett DL, Haynes RB, Guyatt GH, Tugwell P (1991) Clinical Epidemiology 2nd ed., Boston : Little Brown & Company.
31. U.S. Department of Health and Human Services (HHS) (2006) Healthy People 2010: With Understanding and Improving Health and Objectives for Improving Health 2nd ed. Washington, DC : U.S. Government Printing Office, November 2000. More information available at http://www.healthypeople.gov accessed October 31, 2006.
32. Viviani GL (2002) Lercanidipine in type II diabetic patients with mild to moderate arterial hypertension. J Cardiovasc Pharmacol 40 : 133 139.
33. Weir MR, Rosenberger C, Fink JC (2001) Pilot study to evaluate a water displacement technique to compare effects of diuretics and ACE inhibitors to alleviate lower extremity edema due to dihydropyridine calcium antagonists. Am J Hypertens 14 : 963 968.